Eris Lifesciences (NSE:ERIS) FCF Margin % : 0.00% (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Eris Lifesciences FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Eris Lifesciences's Free Cash Flow for the three months ended in Mar. 2024 was ₹0 Mil. Eris Lifesciences's Revenue for the three months ended in Mar. 2024 was ₹5,473 Mil. Therefore, Eris Lifesciences's FCF Margin % for the quarter that ended in Mar. 2024 was 0.00%.

As of today, Eris Lifesciences's current FCF Yield % is 2.99%.

The historical rank and industry rank for Eris Lifesciences's FCF Margin % or its related term are showing as below:

NSE:ERIS' s FCF Margin % Range Over the Past 10 Years
Min: -33.08 Med: 18.6 Max: 29.31
Current: 17.92

During the past 12 years, the highest FCF Margin % of Eris Lifesciences was 29.31%. The lowest was -33.08%. And the median was 18.60%.

NSE:ERIS's FCF Margin % is ranked better than
87.74% of 1028 companies
in the Drug Manufacturers industry
Industry Median: 0.06 vs NSE:ERIS: 17.92

Eris Lifesciences FCF Margin % Historical Data

The historical data trend for Eris Lifesciences's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eris Lifesciences FCF Margin % Chart

Eris Lifesciences Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

FCF Margin %

Get a 7-Day Free Trial

11.33

29.31

19.40

-33.08

17.92

Eris Lifesciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Eris Lifesciences's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Eris Lifesciences's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Eris Lifesciences's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eris Lifesciences's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Eris Lifesciences's FCF Margin % falls into.

Eris Lifesciences FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Eris Lifesciences's FCF Margin for the fiscal year that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Mar. 2024 )	/	Revenue (A: Mar. 2024 )
	=	3568.43	/	19912.95
	=	17.92 %

Eris Lifesciences's FCF Margin for the quarter that ended in Mar. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Mar. 2024 )	/	Revenue (Q: Mar. 2024 )
	=	0	/	5472.65
	=	0.00 %

Eris Lifesciences FCF Margin % Related Terms

Thank you for viewing the detailed overview of Eris Lifesciences's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Eris Lifesciences (NSE:ERIS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eris Lifesciences Ltd (NSE:ERIS) » Definitions » FCF Margin %

Traded in Other Exchanges

540596:India

Address

Ramdas Road, Plot No. 142/2, Shivarth Ambit, Off SBR, Near Swati Bungalows, Bodakdev, Ahmedabad, GJ, IND, 380054

Website

https://www.eris.co.in

Eris Lifesciences Ltd is an India-based company engaged in the manufacturing and sale of branded pharmaceutical formulations. It focuses on Lifestyle therapies such as Diabetes Care, Cardiac Care, Nutrition, Central Nervous System, and others. The company operates in a single segment that is pharmaceuticals. Some of its brands include Glimisave, Cyblex, Eritel, Atorsave and Crevast.

Eris Lifesciences (NSE:ERIS) Headlines

No Headlines